C Glanzmann
Impact in
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
-
- Oral health in cancer treatment
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 16
- Cancer Diagnosis and Treatment 8
-
- Head and Neck Cancer Studies 14
- Co-authors
- Klaus W. Grätz (1 shared paper)Martin Pruschy (7 shared papers)Stephan Bodis (7 shared papers)Gabriela Studer (5 shared papers)Urs M. Lütolf (7 shared papers)Andreas K. Buck (1 shared paper)Gustav K. von Schulthess (1 shared paper)Katrin D. M. Stumpe (1 shared paper)
- Journals
- Radiotherapy and Oncology (4 papers)British Journal of Cancer (3 papers)Strahlentherapie und Onkologie (2 papers)Acta Oncologica (1 paper)RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (1 paper)
- Partner nations
- SwitzerlandGermanyEgypt
In The Last Decade
C Glanzmann
62 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 76
- Otorhinolaryngology 237
- Pulmonary and Respiratory Medicine 306
- Pathology and Forensic Medicine 167
- Radiology, Nuclear Medicine and Imaging 209
- Genetics 97
Countries citing papers authored by C Glanzmann
This map shows the geographic impact of C Glanzmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Glanzmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Glanzmann more than expected).
Fields of papers citing papers by C Glanzmann
This network shows the impact of papers produced by C Glanzmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Glanzmann. The network helps show where C Glanzmann may publish in the future.
Co-authors
The 25 scholars most cited alongside C Glanzmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 199 | |
| 2 | 1995 | 135 | |
| 3 | 2001 | 135 | |
| 4 | 2006 | 90 | |
| 5 | 1994 | 79 | |
| 6 | 2006 | 70 | |
| 7 | The phosphatidylinositide 3'-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C. | 2001 | 60 |
| 8 | 2003 | 52 | |
| 9 | Differential p53-dependent mechanism of radiosensitization in vitro and in vivo by the protein kinase C-specific inhibitor PKC412. | 2001 | 44 |
| 10 | Protein kinase C inhibitor and irradiation-induced apoptosis: relevance of the cytochrome c-mediated caspase-9 death pathway. | 2000 | 31 |
| 11 | Considerations in the radiation treatment of intracranial ependymoma. Prognosis in 24 own cases and results in published series after different techniques of radiation treatment. | 1980 | 27 |
| 12 | Acute toxicity of curative radiotherapy in elderly patients. | 1996 | 25 |
| 13 | 1999 | 24 | |
| 14 | E2F-1 has properties of a radiosensitizer and its regulation by cyclin A kinase is required for cell survival of fibrosarcoma cells lacking p53. | 1999 | 24 |
| 15 | Radiotherapy for carcinomas of the head and neck in elderly patients. | 1996 | 22 |
| 16 | Subsequent malignancies in patients treated with 131-iodine for thyroid cancer. | 1992 | 22 |
| 17 | [Irradiation therapy of vertebral angionomas: results in 62 patients during the years 1939 to 1975 (author's transl)]. | 1977 | 18 |
| 18 | 1989 | 17 | |
| 19 | 2013 | 13 | |
| 20 | The risk of chronic progressive radiation myelopathy. | 1976 | 12 |
About C Glanzmann
C Glanzmann is a scholar working on Oncology, Otorhinolaryngology, Endocrinology, Diabetes and Metabolism, Surgery and Pulmonary and Respiratory Medicine, having authored 67 papers that have together received 1.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (14 papers), Glioma Diagnosis and Treatment (9 papers), Cancer Diagnosis and Treatment (8 papers), Thyroid Cancer Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Management of metastatic bone disease (3 papers). The work is most often cited by research in Otorhinolaryngology (237 citations), Pulmonary and Respiratory Medicine (306 citations), Pathology and Forensic Medicine (167 citations), Radiology, Nuclear Medicine and Imaging (209 citations) and Genetics (97 citations). C Glanzmann has collaborated with scholars based in Switzerland, Germany and Egypt. Frequent co-authors include Klaus W. Grätz, Martin Pruschy, Stephan Bodis, Gabriela Studer, Urs M. Lütolf, Andreas K. Buck, Gustav K. von Schulthess, Katrin D. M. Stumpe, Hans C. Steinert and P Huguenin. Their work appears in journals such as Radiotherapy and Oncology, British Journal of Cancer, Strahlentherapie und Onkologie, Acta Oncologica and RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.